Client of a consultant lobbyist
Vial
- Meetings this Parliament
- 11
- With MPs
- 3
- Since Nov 2021
- 11
- Active registrations
- 0
Most recent reported meeting: Nov 27, 2025.
Lobbying by Vial: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Burton Bailey Conservative 1
- Maggie Chi Liberal 1
- Marcus Powlowski Liberal 1
Institutions
- Health Canada (HC)5
- House of Commons3
- Prime Minister's Office (PMO)2
- Innovation, Science and Economic Development Canada (ISED)1
Registrations in effect
Vial has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.
Reported meetings
Spreadsheet-
Reported by Stefano Hollands · Consultant
- Jibril Hussein · Senior Policy Advisor, Health Canada (HC)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
- Shahad Khalladi · Senior Policy Advisor, Health Canada (HC)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Sandenga Yeba · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
- Jibril Hussein · Intern, Health Canada (HC)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Salman Arif · Deputy Director, Stakeholder Relations and Outreach, Prime Minister's Office (PMO)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Marcus Powlowski · Member of Parliament
- William Fassett · Chief of Staff, House of Commons
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Maggie Chi · Parliamentary Secretary to the Minister of Health, Health Canada (HC)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Burton Bailey · Member of Parliament for Red Deer
- Jl DeCosta · Director of Parliamentary Affairs, House of Commons
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Yash Nanda · Director of Policy, Prime Minister's Office (PMO)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Aaron Wudrick · Director of Policy, House of Commons
- Ayla Dumais · Stakeholder Relations Coordinator, House of Commons
- Luhan Yao · Policy Advisor, House of Commons
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Celia Lourenco · Associate Assistant Deputy Minister, Health Canada (HC)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
-
Reported by Stefano Hollands · Consultant
- Sandenga Yeba · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
Raising awareness on the role of pharmaceuticals in Canada’s healthcare system and enhancing the efficiency of the regulatory process. This includes reducing red tape and system barriers which delay testing. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.